NT69L: A neurotensin receptor agonist for treatment of neuropsychiatric diseases

被引：0
|
作者：
Richelson, E [1 ]
Boules, M [1 ]
Fredrickson, P [1 ]
机构：
[1] Mayo Clin, Jacksonville, FL 32224 USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2005年 / 30卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [41] Regulation of the neurotensin NT1 receptor in the developing rat brain following chronic treatment with the antagonist SR 48692
    Lépée-Lorgeoux, I
    Betancur, C
    Souazé, F
    Rostène, W
    Bérod, A
    Pélaprat, D
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2000, 60 (03) : 362 - 369
  • [42] Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication
    Hashimoto, Kenji
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 127 (01) : 6 - 9
  • [43] LYMPHOMAS AS ESTROGEN RELATED DISEASES - POSSIBLE TARGET FOR ESTROGEN RECEPTOR BETA AGONIST TREATMENT.
    Yakimchuk, K.
    Hasni, M. S.
    Guan, J.
    Nilsson, S.
    Jondal, M.
    Sander, B.
    Okret, S.
    [J]. HAEMATOLOGICA, 2013, 98 : 124 - 124
  • [44] Saffron (Crocus sativus L.): A Source of Nutrients for Health and for the Treatment of Neuropsychiatric and Age-Related Diseases
    El Midaoui, Adil
    Ghzaiel, Imen
    Vervandier-Fasseur, Dominique
    Ksila, Mohamed
    Zarrouk, Amira
    Nury, Thomas
    Khallouki, Farid
    El Hessni, Aboubaker
    Ibrahimi, Salama Ouazzani
    Latruffe, Norbert
    Couture, Rejean
    Kharoubi, Omar
    Brahmi, Fatiha
    Hammami, Sonia
    Masmoudi-Kouki, Olfa
    Hammami, Mohamed
    Ghrairi, Taoufik
    Vejux, Anne
    Lizard, Gerard
    [J]. NUTRIENTS, 2022, 14 (03)
  • [45] Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases
    Schaecke, H.
    Zollner, T. M.
    Doecke, W. D.
    Rehwinkel, H.
    Jaroch, S.
    Skuballa, W.
    Neuhaus, R.
    May, E.
    Zuegel, U.
    Asadullah, K.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (04) : 1088 - 1103
  • [46] Development of Cilofexor, an Intestinally-Biased Farnesoid X Receptor Agonist, for the Treatment of Fatty Liver DiseaseS
    Hollenback, David
    Hambruch, Eva
    Fink, Gero
    Birkel, Manfred
    Schulz, Andreas
    Hornberger, Martin
    Liu, Kathy
    Staiger, Kelly MacLennan
    Krol, Helen Desiree
    Deuschle, Ulrich
    Steeneck, Christoph
    Kinzel, Olaf
    Liles, John T.
    Budas, Grant
    Watkins, William J.
    Kremoser, Claus
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2024, 389 (01): : 61 - 75
  • [47] RYI-018: A Monoclonal Antibody Cannabinoid Receptor 1 Inverse Agonist For The Treatment of Metabolic Diseases
    Kretz-Rommel, Anke
    Ferrini, Roger
    Mann, Derek
    Shi, Lei
    Yang, Teddy
    Glicklich, Alan
    Grayson, Paul
    [J]. HEPATOLOGY, 2016, 64 : 581A - 581A
  • [48] Biased agonism in drug discovery: Is there a future for biased 5-HT1A receptor agonists in the treatment of neuropsychiatric diseases?
    Salaciak, Kinga
    Pytka, Karolina
    [J]. PHARMACOLOGY & THERAPEUTICS, 2021, 227
  • [49] Neladenoson Bialanate Hydrochloride: A Prodrug of a Partial Adenosine A1 Receptor Agonist for the Chronic Treatment of Heart Diseases
    Meibom, Daniel
    Albrecht-Kuepper, Barbara
    Diedrichs, Nicole
    Huebsch, Walter
    Kast, Raimund
    Kraemer, Thomas
    Krenz, Ursula
    Lerchen, Hans-Georg
    Mittendorf, Joachim
    Nell, Peter G.
    Suessmeier, Frank
    Vakalopoulos, Alexandros
    Zimmermann, Katja
    [J]. CHEMMEDCHEM, 2017, 12 (10) : 728 - 737
  • [50] The selective glucocorticoid receptor agonist mapracorat displays a favourable safety-efficacy ratio for the topical treatment of inflammatory skin diseases in dogs
    Baumer, Wolfgang
    Rossbach, Kristine
    Schmidt, Bernard H.
    [J]. VETERINARY DERMATOLOGY, 2017, 28 (01) : 46 - +
12345